Business & Profession

Google Glass is the latest iteration of wearable computers that use head-up displays. Here, we examine how it works and assess the potential contribution that Glass might make in the ophthalmology clinic.

Why I offer implantable miniature telescopes (IMTs) to my patients with bilateral end-stage macular degeneration.

A meta-analysis turns the premise that statin use increases the risk of cataract development on its head

Can Hoya IOLs regain market position after being withdrawn for the best part of a year?

What is SCHWIND eye-tech-solutions known for? We develop, produce and market a comprehensive product portfolio for the treatment of ametropia and corneal diseases. This includes diagnostic systems, software modules for individual treatment planning, and nanosecond and excimer laser systems.

How do you translate a good idea into a physical, purchasable product? Technical, medical, regulatory and business skills are a must, as is an immense ability to resist pressure – especially when your device measures it.

With an ever-growing market and new treatment options on hand, presbyopia offers an attractive business proposition. Understanding the patient and building your practice around her/him is key to success. Here’s how we have done it.

Well over 1,000 different proteins have been cataloged in the vitreous humor. Here’s how they break down.

Retinal implants offer hope for the treatment of inherited blindness. Clinical trials of battery-powered subretinal and epiretinal devices have demonstrated that patients with retinitis pigmentosa, blind for many years, can once again recognize objects.

In the event of an oculolinctus craze, we are ready (thanks to The Daily Mail and others). This summer, Western media leapt upon a post on Japanese curation site Naver Matome which detailed a sudden increase in the practice of oculolinctus.